Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
Chubb
Johnson and Johnson
Healthtrust
US Department of Justice
Colorcon
Baxter
Merck
Moodys

Generated: October 17, 2017

DrugPatentWatch Database Preview

Nizatidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nizatidine and what is the scope of nizatidine patent protection?

Nizatidine
is the generic ingredient in three branded drugs marketed by Mylan Pharms Inc, Smithkline Beecham, Dr Reddys Labs Ltd, Watson Labs, Glenmark Generics, Pfizer, Ani Pharms Inc, Amneal Pharms, Sandoz, Apotex Inc, and Braintree, and is included in thirteen NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Nizatidine has two patent family members in two countries.

There are seven drug master file entries for nizatidine. Nineteen suppliers are listed for this compound.

Summary for Generic Name: nizatidine

US Patents:1
Tradenames:3
Applicants:11
NDAs:13
Drug Master File Entries: see list7
Suppliers / Packagers: see list19
Bulk Api Vendors: see list43
Clinical Trials: see list8
Patent Applications: see list4,716
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nizatidine at DailyMed

Pharmacology for Ingredient: nizatidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
AXID AR
nizatidine
TABLET;ORAL020555-001May 9, 1996OTCYesYes► Subscribe► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-001Apr 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
NIZATIDINE
nizatidine
CAPSULE;ORAL076178-001Jul 5, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
NIZATIDINE
nizatidine
CAPSULE;ORAL075806-002Jul 5, 2002ABRXNoYes► Subscribe► Subscribe► Subscribe
Braintree
AXID
nizatidine
SOLUTION;ORAL021494-001May 25, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Watson Labs
NIZATIDINE
nizatidine
CAPSULE;ORAL075616-001Jul 9, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
NIZATIDINE
nizatidine
CAPSULE;ORAL077314-002Sep 15, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
NIZATIDINE
nizatidine
CAPSULE;ORAL075616-002Jul 9, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
NIZATIDINE
nizatidine
CAPSULE;ORAL075461-001Jul 8, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
NIZATIDINE
nizatidine
CAPSULE;ORAL075806-001Jul 5, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nizatidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-002Apr 12, 1988► Subscribe► Subscribe
Smithkline Beecham
AXID
nizatidine
CAPSULE;ORAL019508-001Apr 12, 1988► Subscribe► Subscribe
Pfizer
AXID AR
nizatidine
TABLET;ORAL020555-001May 9, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: nizatidine

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2004009077► Subscribe
Australia2003247769► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Boehringer Ingelheim
McKesson
Dow
Chinese Patent Office
Moodys
Cantor Fitzgerald
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot